Although coronary artery bypass grafting has been the standard of care for patients with complex coronary artery disease for over 50 years, the evolution of graft patency over time in the left versus the right coronary systems remains poorly documented. This systematic review and meta-analysis aimed to characterize the evolution of graft patency over time comparing the left (excluding left anterior descending artery) and right coronary systems, with an emphasis on the comparison of venous versus arterial grafts and symptomatic versus asymptomatic patients. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and MEDLINE from inception to August 2016. We also searched clinical trials registers and reference lists of relevant studies. We included randomized clinical trials and observational studies comparing graft patency in the left versus the right coronary systems. Our outcome was graft patency defined as a binary variable according to whether grafts were reported as patent or failed at the time of angiogram. Data collection and analysis were performed according to the methodological recommendations of the Cochrane Collaboration. From a total 2275 papers, 52 studies were included in the qualitative analysis and 48 studies (including 36 006 grafts) in the meta-analysis. There was a 3.3% significant difference between the left-sided and rightsided graft patency, and the difference appeared to increase over time. Furthermore, patency of arterial grafts was higher in the left coronary system, while venous grafts performed similarly irrespective of the coronary circulation. Symptom recurrence also seemed related to a higher failure rate in the right coronary circulation. However, the high degree of heterogeneity precluded drawing definite conclusions. This metaanalysis suggested that graft patency might be better for left-sided vessels and that this difference might be driven by the better performance of arterial grafts in the left coronary system. However, evidence currently available is limited, and further research is warranted to understand whether certain grafts achieve better patency in the right versus the left coronary circulations.
INTRODUCTION
Despite over 50 years of coronary artery bypass grafting, there is little specific documentation of the fate of bypass grafts, whether artery or vein, when placed to the left coronary artery (LCA) or right coronary artery (RCA) systems [1] . Apart from the wellestablished better patency of left internal mammary artery (LIMA) grafts anastomosed to the left anterior descending artery (LAD) [2] , which has become the standard worldwide, data regarding other conduits and targets remains contradictory. This is an important issue because the effectiveness of coronary artery bypass surgery is directly related to graft patency, with compelling evidence showing that graft failure is the leading cause of both short-term [3] and long-term [4] adverse postoperative clinical outcomes.
In view of the limited evidence currently available, the aim of this review and meta-analysis was to compare the fate of grafts anastomosed to the RCA and LCA systems (excluding left internal mammary artery to LAD grafts) and to determine whether there was a difference between arterial and venous grafts and symptomatic and asymptomatic patients.
METHODS

Study design
We performed a systematic review and meta-analysis according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement [5] and the Cochrane Collaboration [6] .
Search strategy
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library and MEDLINE in PubMed from inception to August 2016. This was complemented by handsearching reference lists of relevant studies and clinical trial registries (August 2016). We did not apply limits by publication language, status or date. Further details on search strategies are described in the protocol (Supplementary Material, Study Protocol).
Selection criteria
We included randomized controlled trials (RCTs) and observational studies comparing graft patency in the left versus right coronary systems (inclusion and exclusion criteria specified in the Supplementary Material, Study Protocol).
Definition of variables
Graft patency rates were calculated as the number of patent grafts divided by the total number of grafts. The time of graft failure was not possible to establish as it could have occurred at any time between the operation and the angiogram. Therefore, we analysed graft patency as a binary variable (failed or patent) as recorded at the time of the angiogram in individual studies.
We analysed graft patency irrespective of the time of follow-up and also separately for several time points: discharge, 1 year, 3 years and 5 years. LIMA-to-LAD grafts were excluded from the analysis as their patency is well established to be superior to all other grafts.
Overall graft patency was computed for the LCA and RCA systems as left-sided graft patency minus right-sided graft patency (positive graft patency difference favours left and negative favours right). Subgroup analysis was performed for venous and arterial grafts, asymptomatic and symptomatic patients and type of studies (RCTs versus observational). Symptomatic status was determined based on whether graft patency was assessed at a predefined follow-up (asymptomatic patients) or due to recurrence of symptoms (symptomatic patients).
Study selection and data collection
Two review authors independently screened all identified references according to predefined inclusion criteria. Full-text articles of those references were retrieved and reviewed for final inclusion according to prespecified inclusion and exclusion criteria. Disagreements were resolved by consensus.
Data regarding graft patency was obtained from published trial reports. One author collated outcome data into a master database and performed quality assessment, with a second author verifying its accuracy.
Risk-of-bias assessment
Risk of bias of individual studies was assessed according to the recommendations of the Cochrane Collaboration [6] for RCTs and the risk of bias in non-randomised studies of interventions (ROBIN-I) tool [7] for observational studies.
Statistical analysis and evidence synthesis
Meta-analyses were performed to calculate overall patency rates for subgroups of patients comparing left-versus right-sided grafts. Graft patency difference was computed by subtracting the right graft patency from the left graft patency. Meta-analyses were carried out for each subgroup overall and for several time periods (<1 month, 1 month to 1 year, 1-5 years and >5 years). For the overall measure, only the longer follow-up period was considered for studies with repeated observations. Outcome and effect measures were reported as risk difference with 95% confidence intervals. The overall meta-analytical effect size was estimated using the randomeffects model and the restricted maximum likelihood method. The v 2 Q statistics and I 2 statistics were used to assess heterogeneity. In order to assess and test the hypothesis regarding potential moderators of heterogeneity, we used random-effects meta-regression (mixed-effects) models. The coefficients from these models estimate the relationship between the average true effect/outcome in the population of studies and the moderator variables included in the models and assess the heterogeneity explained by those moderator variables. We performed univariable and multivariable meta-regression models. Potentially relevant moderators, significant in the univariable analysis defined as P-value <0.1, were entered in the final multivariable meta-regression model. To conduct meta-analysis and meta-regression analysis, we used the metaphor R package [8] as computational back-end through the cross-platform software program OpenMeta[Analyst] [9] . A P-value <0.05 was considered statistically significant for all analyses.
RESULTS
Study selection
The search strategy resulted in 2273 papers, of which 52 met with the inclusion criteria. A further 2 papers were identified on reference lists of the retained papers. Most studies were excluded because they did not compare LCA versus RCA systems (Supplementary Material, PRISMA Flow Diagram). Despite being included in this review, 4 studies were excluded from the quantitative analysis due to insufficient data [10] [11] [12] [13] .
Study characteristics
The main findings for overall, left-sided and right-sided graft patency for each of the 52 studies are summarized in Table 1 . There were 23 RCTs and 29 observational studies. Comparison of graft patency between the left and right coronary systems was not the primary end-point of any of those studies, and therefore, all studies can be considered as providing observational data for the purpose of this review. Graft patency was assessed most commonly to compare different surgical techniques or pharmaceutical interventions in RCTs. Most non-randomized studies were case series reporting the outcomes of specific surgical techniques, which included assessment of graft patency as part of the follow-up.
Risk of bias within studies
The RCTs included in this study had a low risk of bias for most criteria (Supplementary Material, Risk of bias assessment). Although blinding of professionals, particularly surgeons, was not possible in most trials due to the nature of the intervention, this is unlikely to have influenced the comparison of graft patency between the left-sided and right-sided grafts because this was not the aim of the study. In addition, a few trials had a high attrition rate during follow-up, and the patients who underwent graft patency assessment might have been different from those who did not. As the randomization was not performed for the comparison of left-sided versus right-sided graft patency, RCTs can be considered as providing observational data for the purpose of this review; and in this sense, all included studies may be thought of as non-randomized studies. Regarding observational studies, the overall risk of bias was moderate with high risk of bias in patient selection and measurement of outcomes. For retrospective studies, there was a moderate risk of inaccurate or incomplete information. Most studies did not account for potential confounding when comparing graft patency of left and right circulation systems, because this was not the main objective of the analysis in most studies. This was also true for RCTs, and it may possibly entail a high risk of bias for most studies included.
Graft patency for right versus left coronary systems. A total of 48 studies, comprising 36 006 grafts (11 351 on the LCA and 11 730 on the RCA systems), were included in the pooled analysis of overall graft patency. There was a 3.3% significant difference between the left and right graft patency, and the difference appeared to increase over time from 0.5% within a month to over 4.5% at 5 years ( Fig. 1 and Supplementary Material, Fig.  S10 ). The difference was more marked in observational studies than in RCTs. However, the latter studies were older and more commonly used vein grafts only.
Graft patency for arterial versus venous grafts. In arterial grafts, left-sided grafts achieved a 6.3% significantly higher patency than right-sided grafts, and the difference also seemed to increase over time ( Fig. 2 and Supplementary Material, Fig.  S13 ). On the contrary, venous grafts appeared to perform better on the RCA circulation, but the difference failed to reach statistical significance ( Fig. 3 and Supplementary Material, Fig. S16 ).
Graft patency for symptomatic versus asymptomatic patients. Overall, left-sided grafts outperformed right-sided grafts in both symptomatic (by 8%) and asymptomatic patients (by 2%), but the difference only reached statistical significance in the latter (Supplementary Material, Figs S4-S9 ).
DISCUSSION
The main findings of this review were that (i) overall graft patency was higher for non-LAD left-sided grafts than right-sided grafts; (ii) this difference was largely driven by a higher patency of arterial rather than venous grafts in the LCA system, as the latter appeared to perform better in the RCA system and (iii) differences in graft patency varied according to the symptomatic status with a potentially higher failure rate of right-sided arterial grafts in symptomatic patients.
Overall graft patency was superior in the LCA system due to the superior performance of arterial grafts. This is in keeping with other evidence, which suggests that for both arterial and venous grafts, patency is highest when bypassing the LAD and lowest when bypassing the main RCA, with bypass grafts to diagonal arteries, circumflex artery and posterior descending artery somewhere in between [2, 13, 18, 47, 62, 63] . However, controversy remains on whether venous grafts in the RCA system are more prone to intimal hyperplasia [64] and failure [63] or not [11] . Furthermore, whether the apparent superior patency of arterial grafts to the left side will eventually lead to improved clinical outcomes including longevity
is not yet known. The interim 5-year analyses of the Arterial Revascularisation Trial (ART) [65] showed no difference in mortality or major adverse cardiovascular events between the unilateral or bilateral internal mammary artery, but a much clearer answer will be given by the 10-year primary outcome analyses.
Graft failure results from a complex interplay of mechanisms, which differ not only between the RCA and LCA circulations but also between the arterial and venous grafts. While early graft failure is most frequently due to technical errors and thus less influenced by the location of the coronary target, late graft failure is mainly caused by intimal hyperplasia and arteriosclerosis. Optimal medical therapy, particularly antiplatelet agents [66] and statins [67] , is pivotal in reducing intimal hyperplasia and progression of atherosclerosis, which are the primary mechanisms leading to venous graft failure [62, 64] and explain the observed attrition of venous graft patency over time [63] .
On the contrary, arterial graft patency remained stable over time, reflecting the relative resistance of arterial grafts to arteriosclerosis. However, arterial grafts are susceptible to native coronary artery competitive flow, which leads to graft constriction and eventually atrophy and occlusion [62] . Competitive flow seems to have a more detrimental effect on arterial graft patency in the RCA system than in the LCA system [2] , perhaps due to the larger calibre of the RCA, which results in a large residual lumen of the native artery for the same degree of stenosis. This is the rationale for the contraindication to use arterial grafts in the RCA with <70% stenosis [2] , in which case grafting the posterior descending artery might be a better alternative. In keeping with this, we demonstrated that arterial grafts achieved a significantly higher patency in the LCA system, while there was a non-significant trend towards venous grafts performing better in the RCA system. In addition, graft spasm most frequently affects arterial grafts, particularly the radial artery, but not venous grafts in the early postoperative period. Adequate harvesting technique complemented with topical application of vasodilators can reduce spasm and its deleterious consequences [68] . Although it tends to resolve over time, spasm can lead to graft constriction and eventual failure [69] [70] [71] . Further research is warranted to understand whether different arterial conduits have different susceptibility to spasm and competitive flow and are thus more suitable to different coronary territories.
The better patency of grafts anastomosed to the LCA territory might be explained by differences in several physiological factors that influence graft patency. On the one hand, blood flow to the LCA circulation is predominantly diastolic, while around 50% of the blood flow to the RCA occurs in systole because of a thinner right ventricular wall [72] . On the other hand, graft position and configuration tend to be less favourable to the RCA system, which can be more complex to reach from the aorta and may be adversely influenced by angulation at the acute margin of the heart.
We found that overall graft patency was higher in the LCA than in the RCA system for both asymptomatic and symptomatic patients, with a larger difference observed in symptomatic than in asymptomatic patients (8% and 2%, respectively). Moreover, symptomatic patients had better graft patency on the LCA system for both arterial and venous grafts, thus suggesting that symptom recurrence may be related to graft failure in the RCA system irrespective of the type of conduit.
Limitations
Caution is needed when interpreting the findings of this systematic review and meta-analysis due to the significant heterogeneity, which is in itself an important finding. Meta-regression suggested that part of this heterogeneity may be explained by the type of study, type of graft, duration of follow-up and geographical location (Supplemental Material, Meta-regression). The high heterogeneity demonstrates that evidence currently available is insufficient to provide a definite answer to the study question, hence further research is warranted to understand which graft achieves better patency in the right and left coronary systems.
Most studies comparing coronary artery bypass graft patency were small, single centre, observational and opportunistic. Some studies reported data obtained from patients undergoing angiography for clinical indications, usually recurrent ischaemia, which might negatively bias graft patency rates. On the other hand, in studies that systematically performed follow-up angiography, compliance with follow-up might have positively influenced the results. Another potential source of bias is the fact that the decision on which conduits were used in each coronary anastomosis was left to the surgeon's discretion. Surgeons might have preferentially used arterial grafts to bypass better native coronary vessels, thus leaving venous grafts as the last resource for poor targets.
In addition, the 52 studies included in this review extended across a long time period, during which significant improvements occurred with regard to surgical technique and perioperative care. However, the emphasis of this review was on the comparison between the left-and right-sided grafts, regardless of the absolute patency rate reported in individual studies. In keeping with this, we considered that within each study, both subgroups of grafts (to the LCA and RCA systems) would have been submitted to the same pre-, intra-and postoperative conditions, thus allowing a direct comparison between their outcomes. The inclusion of markedly different studies precluded direct comparison of graft patency. In addition, we considered that, although graft patency was affected by many factors, these would be evenly distributed within each study and their effect would be diluted due to the large number of grafts included in this analysis. Although it would have been interesting to compare different types of arterial grafts when anastomosed to right-and left-sided vessels, those data were only reported by few studies, which rendered any statistical analysis unreliable. The impact of native coronary stenosis on graft patency could not be estimated as this information was not provided by the original studies.
CONCLUSION
This review analysed the evolution of graft patency over time on the LCA and RCA systems, with an emphasis on the comparison of venous versus arterial grafts and symptomatic versus asymptomatic patients. Overall graft patency seemed to be better in the LCA territory, and this higher patency rate seemed to be driven by better performance of arterial grafts to the LCA system, as venous graft patency was similar in both circulations. Furthermore, symptom recurrence appeared to be associated with higher graft failure in the RCA circulation independently of the type of conduit. However, the high degree of heterogeneity precluded drawing definite conclusions and further research in warranted to understand whether different conduits afford better graft patency in the left versus the right coronary systems.
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